Literature DB >> 12414620

Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer.

Vicki L J Whitehall1, Coral V A Wynter, Michael D Walsh, Lisa A Simms, David Purdie, Nirmala Pandeya, Joanne Young, Stephen J Meltzer, Barbara A Leggett, Jeremy R Jass.   

Abstract

Colorectal cancer (CRC) has traditionally been classified into two groups: microsatellite stable/low-level instability (MSS/MSI-L) and high-level MSI (MSI-H) groups on the basis of multiple molecular and clinicopathologic criteria. Using methylated in tumor (MINT) markers 1, 2, 12, and 31, we stratified 77 primary CRCs into three groups: MINT++ (>2), MINT+ (1-2), and MINT- (0 markers methylated). The MSS/MSI-L/MINT++ group was indistinguishable from the MSI-H/MINT++ group with respect to methylation of p16(INK4a), p14(ARF), and RIZ1, and multiple morphological features. The only significant difference between MSI-H and non-MSI-H MINT++ cancers was the higher frequency of K-ras mutation (P < 0.004) and lower frequency of hMLH1 methylation (P < 0.001) in the latter. These data demonstrate that the separation of CRC into two nonoverlapping groups (MSI-H versus MSS/MSI-L) is a misleading oversimplification.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414620

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

Review 1.  Serrated adenoma of the colorectum: a lesion with teeth.

Authors:  Jeremy R Jass
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

2.  Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?

Authors:  K Baker; Y Zhang; C Jin; J R Jass
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

3.  Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer.

Authors:  Noriko Tanaka; Curtis Huttenhower; Katsuhiko Nosho; Yoshifumi Baba; Kaori Shima; John Quackenbush; Kevin M Haigis; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

4.  Colorectal cancer "methylator phenotype": fact or artifact?

Authors:  Charles Anacleto; Andréia M Leopoldino; Benedito Rossi; Fernando A Soares; Ademar Lopes; José Cláudio C Rocha; Otávia Caballero; Anamaria A Camargo; Andrew J G Simpson; Sérgio D J Pena
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 5.  Molecular classification and correlates in colorectal cancer.

Authors:  Shuji Ogino; Ajay Goel
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

6.  CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.

Authors:  Shuji Ogino; Katsuhiko Nosho; Gregory J Kirkner; Takako Kawasaki; Jeffrey A Meyerhardt; Massimo Loda; Edward L Giovannucci; Charles S Fuchs
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

7.  Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.

Authors:  Takako Kawasaki; Katsuhiko Nosho; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Reiko Dehari; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

8.  Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy.

Authors:  Patrick Chun; Zev A Wainberg
Journal:  Gastrointest Cancer Res       Date:  2009-09

9.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.

Authors:  T Kambara; L A Simms; V L J Whitehall; K J Spring; C V A Wynter; M D Walsh; M A Barker; S Arnold; A McGivern; N Matsubara; N Tanaka; T Higuchi; J Young; J R Jass; B A Leggett
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

10.  DNA methylation in circulating tumour DNA as a biomarker for cancer.

Authors:  Ruth E Board; Lucy Knight; Alastair Greystoke; Fiona H Blackhall; Andrew Hughes; Caroline Dive; Malcolm Ranson
Journal:  Biomark Insights       Date:  2008-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.